Ascletis Pharma Inc.
HKEX:1672.HK
1.04 (HKD) • At close September 19, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Ascletis Pharma Inc. |
Symbool | 1672.HK |
Munteenheid | HKD |
Prijs | 1.04 |
Beurswaarde | 1,022,051,680 |
Dividendpercentage | 0% |
52-weken bereik | 0.76 - 2.05 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jinzi Jason Wu Ph.D. |
Website | https://www.ascletis.com |
An error occurred while fetching data.
Over Ascletis Pharma Inc.
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China and internationally. The company offers Ritonavir oral tablet, a pharmacokinetic booster of various oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (HKD)
Cijfers zijn in miljoenen (HKD)